Nuclera

Cambridge, United Kingdom · Founded 2013 · Privately Held (backing)

Developer of a protein prototyping system designed to accelerate drug discovery workflows. Nuclera is based in Cambridge, United Kingdom and was founded in 2013. It was valued at $155 million at its Series B in Jul 2022, the last priced event on record. It has raised $166 million across 9 recorded rounds; the latest was an $87 million Series C in Jan 2026.

PMV mark · valuation
$154.5M
Oct 2026
Priced at
its Series B
Jul 2022
Total raised
$166.1M
Last round
Later Stage VC (Series C)
Jan 2026
What is Nuclera worth?
$154.5MPrivateMarketView mark · Oct 2026

Valued at $154.5M at its Series B, Jul 2022. Nothing has traded since.

Free account
More of Nuclera with a free account
  • ·Post-money valuations for 2 rounds
  • ·The complete investor list: 22 names
  • ·Watch Nuclera: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

2 priced rounds · 32 daily marks since · Oct 2019 – Oct 2026
▮▮
Later Stage VC (Series A)rounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Nuclera funding history

9 rounds
DateRoundRaisedPost-money
Jan 2026Later Stage VC (Series C)$87.0M▮
Jun 2024Grant$1.4M▮
Mar 2024Accelerator/Incubator—▮
Jul 2022Later Stage VC (Series B)$67.1M▮
Oct 2019Later Stage VC (Series A)$11.2M▮
Feb 2017Accelerator/Incubator—▮
+ 3 earlier rounds · a free account shows the full history
Unlock post-money valuations

Membership and data by Private Market View

Nuclera valuation

Nuclera was valued at $155 million at its Series B in Jul 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Nuclera raised?

Nuclera has raised $166 million across 9 recorded rounds since 2014. The largest was an $87 million Series C in Jan 2026. 2 of the rounds disclosed a post-money valuation.

How Nuclera's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Nuclera, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Nuclera

What is Nuclera worth?
Nuclera is valued at $154.5M as of Oct 2026. Valued at $154.5M at its Series B, Jul 2022. Nothing has traded since.
How much has Nuclera raised?
Nuclera has raised $166.1M in total funding across 9 recorded rounds.
When did Nuclera last raise?
Nuclera last raised in Jan 2026 (Later Stage VC (Series C)), raising $87.0M.